Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.089 | 0.03 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |